Aveanna Healthcare

AVAH

Market cap $1.95B

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Aveanna Healthcare Holdings Inc. ( AVAH ) Q3 2025 Earnings Call November 6, 2025 10:00 AM EST Company Participants Debbie Stewart - Senior VP & Principal Accounting Officer Jeffrey Shaner - CEO & Director Matt Buckhalter - CFO & Principal Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Brian Tanquilut - Jefferies LLC, Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Raj Kumar - Stephens Inc., Research Division Albert Rice - UBS Investment Bank, Research Division Andrew Mok - Barclays Bank PLC, Research Division John Ransom - Raymond James & Associates, Inc., Research Division Michael Murray David MacDonald - Truist Securities, Inc., Research Division Presentation Debbie Stewart Senior VP & Principal Accounting Officer Good morning, and welcome to Aveanna's third quarter 2025 earnings call. I am Debbie Stewart, the company's Chief Accounting Officer.

The headline numbers for Aveanna (AVAH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

ATLANTA, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended September 27, 2025.

AVAH's solid care-hour growth, stronger reimbursement rates and margin gains are likely to set the stage for another robust quarter.

As part of a trading plan, Paul R. Vigano, a 10% owner of Aveanna Healthcare Holdings Inc. (AVAH 3.10%), sold 1,500,000 indirectly owned shares of the home healthcare services company for approximately $13.5 million on October 24, as disclosed in a recent SEC Form 4 filing.

Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Wednesday.

ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, announced today the pricing of the previously announced secondary offering by certain selling stockholders affiliated with J.H. Whitney Equity Partners VII, LLC (the “Selling Stockholders”) of 10,000,000 shares of its common stock at a public offering price of $9.00 per share (the “Offering”). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of the Company's common stock. The Selling Stockholders will receive all of the net proceeds from the Offering. The Company is not offering any shares of its common stock in the Offering and will not receive any of the proceeds from the sale of the shares offered by the Selling Stockholders. The Offering is expected to settle on October 23, 2025, subject to customary closing conditions.